Providence and Boston biotechs to collaborate on mRNA cancer vaccine


EpiVax Therapeutics and GreenLight BioSciences will share technology to develop mRNA vaccines for oncology.

Previous Mercy Health-Cincinnati taps Atrium Health's Brian Gwyn as market president
Next In-N-Out Burger pushes further east with expansion into Tennessee